BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2876744)

  • 1. Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
    Dougados M; Boumier P; Amor B
    Br Med J (Clin Res Ed); 1986 Oct; 293(6552):911-4. PubMed ID: 2876744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulphasalazine in ankylosing spondylitis.
    Feltelius N; Hällgren R
    Ann Rheum Dis; 1986 May; 45(5):396-9. PubMed ID: 2872857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of sulphasalazine treatment of chronic ankylosing spondylitis: failure to demonstrate a clinical effect.
    Corkill MM; Jobanputra P; Gibson T; Macfarlane DG
    Br J Rheumatol; 1990 Feb; 29(1):41-5. PubMed ID: 1968354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sulfasalazine therapy in spondylarthritis ankylopoietica].
    Winkler V
    Orv Hetil; 1989 Jan; 130(2):77-81. PubMed ID: 2563308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sulfasalazine in the treatment of ankylosing spondylitis].
    Krajnc I
    Lijec Vjesn; 1990; 112(5-6):171-4. PubMed ID: 1978212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of ankylosing spondylitis with salazosulfapyridine. A controlled double-blind study in 60 patients].
    Dougados M; Boumier P; Amor B
    Rev Rhum Mal Osteoartic; 1987 Mar; 54(3):255-60. PubMed ID: 2884723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sulfasalazine in ankylosing spondylitis: a prospective, randomized, double-blind placebo-controlled study and comparison with other controlled studies].
    Schmidt WA; Wierth S; Milleck D; Droste U; Gromnica-Ihle E
    Z Rheumatol; 2002 Apr; 61(2):159-67. PubMed ID: 12056293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulphasalazine (Salazopyrin) in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritis.
    Mielants H; Veys EM; Joos R
    Clin Rheumatol; 1986 Jan; 5(1):80-3. PubMed ID: 2869851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin.
    Davis MJ; Dawes PT; Beswick E; Lewin IV; Stanworth DR
    Br J Rheumatol; 1989 Oct; 28(5):410-3. PubMed ID: 2571386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial.
    Nissilä M; Lehtinen K; Leirisalo-Repo M; Luukkainen R; Mutru O; Yli-Kerttula U
    Arthritis Rheum; 1988 Sep; 31(9):1111-6. PubMed ID: 2901839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment.
    Taylor HG; Beswick EJ; Dawes PT
    Clin Rheumatol; 1991 Mar; 10(1):43-8. PubMed ID: 1676621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfasalazine for ankylosing spondylitis.
    Chen J; Liu C
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004800. PubMed ID: 15846731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of sulphasalazine in ankylosing spondylitis--an interventional study.
    Fraser SM; Sturrock RD
    Br J Rheumatol; 1990 Feb; 29(1):37-9. PubMed ID: 1968353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-modifying effect of etanercept versus sulphasalazine on spinal mobility in patients with ankylosing spondylitis.
    Hendrix S; Koenig A; Li W; Singh A
    J Int Med Res; 2013 Oct; 41(5):1606-11. PubMed ID: 23975857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial.
    Braun J; van der Horst-Bruinsma IE; Huang F; Burgos-Vargas R; Vlahos B; Koenig AS; Freundlich B
    Arthritis Rheum; 2011 Jun; 63(6):1543-51. PubMed ID: 21630245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facial palsy and partial accommodative insufficiency associated with sulphasalazine treatment in a patient with ankylosing spondylitis.
    Magnus JH; Elverland HH; Olsen EG; Husby G
    Scand J Rheumatol; 1993; 22(4):199-201. PubMed ID: 8102809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulphasalazine and ankylosing spondylitis.
    McConkey B
    Br J Rheumatol; 1990 Feb; 29(1):2-3. PubMed ID: 1968352
    [No Abstract]   [Full Text] [Related]  

  • 19. Sulphasalazine and ankylosing spondylitis: an open pilot study.
    Coelho Andrade LE; Atra E; Bosi Ferraz M
    Clin Exp Rheumatol; 1989; 7(6):661-2. PubMed ID: 2575477
    [No Abstract]   [Full Text] [Related]  

  • 20. Desensitization to sulphasalazine in patients with arthritis.
    Koski JM
    Clin Exp Rheumatol; 1993; 11(2):169-70. PubMed ID: 8099541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.